| NDC Code | 0603-2553-21 |
|---|
| Package Description | 100 CAPSULE in 1 BOTTLE, PLASTIC (0603-2553-21) |
|---|
| Product NDC | 0603-2553 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Butalbital, Acetaminophen, Caffeine, And Codeine Phosphate |
|---|
| Non-Proprietary Name | Butalbital, Acetaminophen, Caffeine, And Codeine Phosphate |
|---|
| Dosage Form | CAPSULE |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20020422 |
|---|
| End Marketing Date | 20220930 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA075929 |
|---|
| Manufacturer | Par Pharmaceutical, Inc. |
|---|
| Substance Name | ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE |
|---|
| Strength | 325; 50; 40; 30 |
|---|
| Strength Unit | mg/1; mg/1; mg/1; mg/1 |
|---|
| Pharmacy Classes | Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Full Opioid Agonists [MoA], Methylxanthine [EPC], Opioid Agonist [EPC], Xanthines [CS] |
|---|
| DEA Schedule | CIII |
|---|